QA: Genelux Corp in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001231457_2025_Genelux_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001231457, Genelux Corp

  xvar xval
0 AssetsCurrent 31,548,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,316,000
3 remainder_Assets 1,852,000
4 LiabilitiesCurrent 6,903,000
5 LiabilitiesNoncurrent 1,539,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,706,000
9 ResearchAndDevelopmentExpense 18,998,000
10 remainder_Expenses 0
11 remainder_Revenues 8,000
12 remainder_NetIncome 1,827,000
13 remainder_ComprehensiveNetIncome 50,000
  yvar yval
0 Assets 34,716,000
1 Liabilities 8,442,000
2 Expenses 31,704,000
3 Revenues 8,000
4 StockholdersEquity 26,274,000
5 NetIncome -29,869,000
6 ComprehensiveNetIncome -29,844,000
7 BaseVar 38,373,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.27
9 EconomicCapitalRatio 2.51

Edgar->Model Mapping

Feature Distribution

Change over Time